[Significance of subjective symptoms and diagnostic criteria in initial forms of cerebral circulation insufficiency].
Piracetam was applied to the treatment of 60 patients with initial manifestations of brain circulation failure and stage I circulatory encephalopathy. The drug exerted a beneficial therapeutic effect by reducing high brain vascular resistance (both extra- and intracranial) and by increasing the lowered volume of pulse fluctuations. It made fibrinolytic blood activity and aggregation of formed elements of the blood return to normal. An appreciable antiatherogenic effect was discovered as well. It should be taken into consideration that in patients with a dramatic lowering of pulse fluctuations, the use of piracetam in a dose of 1.6 g/day may enhance headache. In such cases the dose should be reduced.
Eninia
G I
GI
Purinia
I V
IV
Robule
V Kh
VKh
Maĭore
I Kh
IKh
Timofeeva
T N
TN
Berzina
A Ia
AIa
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D002560:Cerebrovascular Circulation; D002561:Cerebrovascular Disorders / Q000175:diagnosis* / Q000188:drug therapy / Q000503:physiopathology; D005260:Female; D006439:Hemodynamics; D006801:Humans; D008297:Male; D008875:Middle Aged; D010889:Piracetam / Q000008:administration & dosage / Q000627:therapeutic use; D013997:Time Factors; D014463:Ultrasonography
D010889:Piracetam
Znachimost' sub"ektivnykh simptomov i diagnosticheskie kriterii pri nachal'nykh formakh nedostatochnosti krovosnabzheniia mozga.